Zofia Zysman‐Colman

ORCID: 0000-0002-1516-9787
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neonatal Respiratory Health Research
  • Cystic Fibrosis Research Advances
  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Pediatric health and respiratory diseases
  • Respiratory and Cough-Related Research
  • Child Nutrition and Water Access
  • Respiratory Support and Mechanisms
  • Infections and bacterial resistance
  • Pharmaceutical studies and practices
  • Congenital Diaphragmatic Hernia Studies
  • Prenatal Screening and Diagnostics
  • Full-Duplex Wireless Communications
  • Cerebrospinal fluid and hydrocephalus
  • Neurogenetic and Muscular Disorders Research
  • Scoliosis diagnosis and treatment
  • Ear and Head Tumors
  • Neuroscience of respiration and sleep
  • Pleural and Pulmonary Diseases
  • Child Nutrition and Feeding Issues
  • Infant Health and Development
  • Respiratory viral infections research
  • Pancreatic and Hepatic Oncology Research
  • Infectious Diseases and Tuberculosis
  • Vascular Malformations and Hemangiomas

McGill University Health Centre
2024-2025

Centre Hospitalier Universitaire Sainte-Justine
2019-2024

Canadian Paediatric Society
2024

Université de Montréal
2021

Children's Hospital of Philadelphia
2020

Faculty (United Kingdom)
2013

McGill University
2013

To describe the characteristics of bronchopulmonary dysplasia (BPD) and respiratory distress syndrome subjects, along with trends in severity mortality associated BPD over past three decades.Retrospective study subjects born between 1980 2008, admitted to Montreal Children's Hospital (Montreal, Quebec). Data were abstracted from hospital records.Gestational age birth weight correlated occurrence each additional week gestation 100 g being an OR developing 0.77 0.89, respectively. was male...

10.1093/pch/18.2.86 article FR Paediatrics & Child Health 2013-02-01

10.1093/pch/pxae102 article cc-by Paediatrics & Child Health 2025-04-03

Abstract This practice point summarizes recommendations from the Canadian Thoracic Society’s 2021 “Guideline update: Diagnosis and management of asthma in preschoolers, children, adults.” New include: a decrease frequency daytime symptoms reliever use to ≤2 per week control criteria; assessing for risk exacerbation; not using as-needed short-acting beta-agonists alone patients at higher option budesonide/formoterol (bud/form) those ≥12 years old if they are unable take daily inhaled...

10.1093/pch/pxae006 article EN Paediatrics & Child Health 2024-04-05

Résumé Le présent point de pratique résume la mise à jour des lignes directrices Société canadienne thoracologie publiée en 2021 sur le diagnostic et prise charge l’asthme chez les enfants d’âge préscolaire, adultes. Ces nouvelles recommandations incluent, parmi critères contrôle l’asthme, une diminution fréquence symptômes diurnes l’utilisation médicaments pour soulager un maximum deux fois par semaine. Elles comprennent également l’évaluation du risque d’exacerbation non-utilisation...

10.1093/pch/pxae005 article FR Paediatrics & Child Health 2024-04-05
Coming Soon ...